ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 617

$793K Total Retail Price of All Prescriptions

Rank: 12 out of 617

551 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,870 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 851 763 1 1
OMEPRAZOLE 578 412 2 3
LISINOPRIL 539 485 3 5
SIMVASTATIN 448 412 4 2
FUROSEMIDE 432 379 5 4
HYDROCODONE-ACETAMINOPHEN 367 230 S3 6 8
POTASSIUM CHLORIDE 331 312 7 10
WARFARIN SODIUM 329 304 8 7
AMLODIPINE BESYLATE 303 284 9 6
METOPROLOL SUCCINATE 296 246 10 12
METFORMIN HCL 246 218 11 9
FENTANYL 238 125 S2 12 45
MELOXICAM 237 173 13 24
HYDROCHLOROTHIAZIDE 228 191 14 13
ZOLPIDEM TARTRATE 208 145 15 23
PAROXETINE HCL 205 191 16 62
GABAPENTIN 186 94 17 16
POLYETHYLENE GLYCOL 3350 181 105 18 32
TRIAMTERENE-HCTZ 180 120 19 47
TRAMADOL HCL 179 93 20 15
MORPHINE SULFATE ER 178 99 S2 21 128
ALLOPURINOL 163 146 22 27
METOPROLOL TARTRATE 162 140 23 11
CARVEDILOL 159 151 24 19
ENALAPRIL MALEATE 158 144 25 34
CYMBALTA 137 60 26 49
ADVAIR DISKUS 135 105 27 38
SPIRIVA 134 110 28 61
PREDNISONE 125 106 29 31
NAMENDA 125 125 29 35
ALENDRONATE SODIUM 119 119 31 25
OXYCONTIN 115 12 S2 32 133
BISOPROLOL-HYDROCHLOROTHIAZIDE 108 94 33 87
PANTOPRAZOLE SODIUM 104 75 34 37
TRAZODONE HCL 103 31 35 51
FLUTICASONE PROPIONATE 101 74 36 36
OXYCODONE HCL-ACETAMINOPHEN 97 13 S2 37 134
NEXIUM 95 76 38 43
BENAZEPRIL HCL 95 82 38 44
CARISOPRODOL 94 0 R 40 178
SPIRONOLACTONE 94 80 40 42
ATORVASTATIN CALCIUM 93 91 42 14
TAMSULOSIN HCL 92 91 43 26
METHADONE HCL 86 23 S2 44 236
DIGOXIN 85 85 45 48
CITALOPRAM HBR 84 64 46 18
OXYCODONE HCL 81 26 S2 47 130
CYCLOBENZAPRINE HCL 81 0 R 47 74
DIOVAN 81 71 47 41
ATENOLOL 80 69 50 17
VERAPAMIL ER 80 75 50 90
ROPINIROLE HCL 78 32 52 66
LOSARTAN POTASSIUM 77 77 53 22
BYSTOLIC 73 59 54 64
GLIMEPIRIDE 72 69 55 33
SINGULAIR 70 21 56 106
VENLAFAXINE HCL ER 70 62 56 76
FLUOXETINE HCL 68 34 58 73
DONEPEZIL HCL 68 68 58 30
AMLODIPINE BESYLATE-BENAZEPRIL 68 58 58 80
DILTIAZEM 24HR CD 65 55 61 117
QUETIAPINE FUMARATE 65 43 61 78
LANTUS SOLOSTAR 64 46 63 115
SYNTHROID 64 64 63 59
CLONIDINE HCL 64 53 63 55
CLOPIDOGREL 61 53 66 53
AZITHROMYCIN 60 44 67 70
DOXAZOSIN MESYLATE 60 48 67 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 48 67 29
PREMARIN 58 53 R 70 108
LEVETIRACETAM 57 38 71 166
LOSARTAN-HYDROCHLOROTHIAZIDE 56 54 72 46
ENDOCET 55 0 S2 73 182
AMITRIPTYLINE HCL 55 41 R 73 56
METOCLOPRAMIDE HCL 55 40 73 125
PHENYTOIN SODIUM EXTENDED 54 28 76 121
AMOXICILLIN 53 33 77 135
SERTRALINE HCL 52 40 78 20
FAMOTIDINE 51 38 79 54
ESCITALOPRAM OXALATE 50 38 80 65
METHYLPREDNISOLONE 50 34 80 208
LYRICA 50 19 80 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.